| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |